Nuzenio

Avexitide

Avexitide news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 6 latest news signals 3 publisher sources 100/100 entity strength

Latest news

Amylyx shifts focus to endocrine drug avexitide with strong cash runway into 2028 and key trial results in 2026 - PluangPluang · Fri, 07 Aug 2026 15:53:04 GMTAmylyx Pharmaceuticals: Avexitide Defines The Endocrine Rebuild (NASDAQ:AMLX) - Seeking AlphaSeeking Alpha · Fri, 07 Aug 2026 15:28:15 GMTAmylyx Pharmaceuticals Q2 Earnings Call Highlights - TradingViewTradingView · Thu, 06 Aug 2026 15:04:22 GMTAmylyx Pharmaceuticals, Inc. 2Q 2026: Net loss $43.4M, EPS $(0.39) — 10-Q Summary - TradingViewTradingView · Thu, 06 Aug 2026 11:11:00 GMTAMLX: LUCIDITY trial for avexitide nears topline data; cash runway extends into 2028 - TradingViewTradingView · Thu, 06 Aug 2026 11:03:57 GMTAmylyx Pharmaceuticals reports Q2 net loss $43.4M, cash $250.8M, runway into 2028 - TradingViewTradingView · Thu, 06 Aug 2026 11:03:01 GMT

Timeline

Fri, 07 Aug 2026 15:53:04 GMTAmylyx shifts focus to endocrine drug avexitide with strong cash runway into 2028 and key trial results in 2026 - Pluang
Fri, 07 Aug 2026 15:28:15 GMTAmylyx Pharmaceuticals: Avexitide Defines The Endocrine Rebuild (NASDAQ:AMLX) - Seeking Alpha
Thu, 06 Aug 2026 15:04:22 GMTAmylyx Pharmaceuticals Q2 Earnings Call Highlights - TradingView
Thu, 06 Aug 2026 11:11:00 GMTAmylyx Pharmaceuticals, Inc. 2Q 2026: Net loss $43.4M, EPS $(0.39) — 10-Q Summary - TradingView
Thu, 06 Aug 2026 11:03:57 GMTAMLX: LUCIDITY trial for avexitide nears topline data; cash runway extends into 2028 - TradingView
Thu, 06 Aug 2026 11:03:01 GMTAmylyx Pharmaceuticals reports Q2 net loss $43.4M, cash $250.8M, runway into 2028 - TradingView

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Avexitide.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

3 distinct publisher/source names are currently connected to this entity page.